Concepedia

Mathew Brock

MB

6

Publications

964

Citations

6

H-Index

2001

Active since

Affiliations

Axion Biosystems (United States)(Current)

United States Food and Drug Administration

Center for Drug Evaluation and Research

Office of Science

Center for Devices and Radiological Health

Mathew Brock is an author at Axion Biosystems (United States) specializing in medicine, cardiology, and cardiovascular disease.

Top concepts

Publications per year

2001–2018

6

Publications

6

International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment

Ksenia Blinova, Qianyu Dang, Daniel Millard et al. · Cell Reports · 2018 · 358 citations · Full text

Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias

Ksenia Blinova, Jayna Stohlman, José Vicente et al. · Toxicological Sciences · 2016 · 271 citations

, , +15

iPSC-Derived Dopamine Neurons Reveal Differences between Monozygotic Twins Discordant for Parkinson’s Disease

Chris M. Woodard, Brian A. Campos, Sheng‐Han Kuo et al. · Cell Reports · 2014 · 221 citations · Full text

, , +23

Deriving dopaminergic neurons for clinical use. A practical approach

Rodolfo Gonzalez, Ibon Garitaonandia, Tatiana Abramihina et al. · Scientific Reports · 2013 · 54 citations · Full text

Comparative analysis of media effects on human induced pluripotent stem cell-derived cardiomyocytes in proarrhythmia risk assessment

Derek Schocken, Jayna Stohlman, José Vicente et al. · Journal of Pharmacological and Toxicological Methods · 2017 · 31 citations

, , +11

Rows per page

1–5 of 6